148 related articles for article (PubMed ID: 11714031)
1. Comparison of the upper gastrointestinal effects of etodolac and aspirin in healthy dogs.
Nishihara K; Kikuchi H; Kanno T; Tanabe S; Sarashina T; Uzuka Y
J Vet Med Sci; 2001 Oct; 63(10):1131-3. PubMed ID: 11714031
[TBL] [Abstract][Full Text] [Related]
2. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs.
Reimer ME; Johnston SA; Leib MS; Duncan RB; Reimer DC; Marini M; Gimbert K
J Vet Intern Med; 1999; 13(5):472-7. PubMed ID: 10499732
[TBL] [Abstract][Full Text] [Related]
3. Effects of deracoxib or buffered aspirin on the gastric mucosa of healthy dogs.
Sennello KA; Leib MS
J Vet Intern Med; 2006; 20(6):1291-6. PubMed ID: 17186840
[TBL] [Abstract][Full Text] [Related]
4. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
[No Abstract] [Full Text] [Related]
5. Gastro-duodenal mucosal changes associated with low-dose aspirin therapy: a prospective, endoscopic study.
Chowdhury A; Ganguly G; Chowdhury D; Santra A; Gupta JD; Roy T
Indian J Gastroenterol; 2001; 20(6):227-9. PubMed ID: 11817775
[TBL] [Abstract][Full Text] [Related]
6. An endoscopic evaluation of the effects of etodolac and diclofenac on the gastric and duodenal mucosa.
van Eeden A; Schotborgh RH; Tytgat GN
Clin Ther; 1990; 12(6):496-502. PubMed ID: 2149673
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase expression and prostanoid production in pyloric and duodenal mucosae in dogs after administration of nonsteroidal anti-inflammatory drugs.
Wooten JG; Blikslager AT; Ryan KA; Marks SL; Law JM; Lascelles BD
Am J Vet Res; 2008 Apr; 69(4):457-64. PubMed ID: 18380576
[TBL] [Abstract][Full Text] [Related]
8. A randomized double-blind comparison of placebo, etodolac, and naproxen on gastrointestinal injury and prostaglandin production.
Laine L; Sloane R; Ferretti M; Cominelli F
Gastrointest Endosc; 1995 Nov; 42(5):428-33. PubMed ID: 8566633
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of gastroduodenal mucosal injuries in aspirin users.
Thongbai T
J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal irritancy, antiinflammatory activity, and prostanoid inhibition in the rat. Differentiation of effects between nabumetone and etodolac.
Melarange R; Gentry C; Durie M; O'Connell C; Blower PR
Dig Dis Sci; 1994 Mar; 39(3):601-8. PubMed ID: 8131699
[TBL] [Abstract][Full Text] [Related]
11. Effects of alendronate on gastric and duodenal mucosa.
Lanza F; Rack MF; Simon TJ; Lombardi A; Reyes R; Suryawanshi S
Am J Gastroenterol; 1998 May; 93(5):753-7. PubMed ID: 9625122
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
[TBL] [Abstract][Full Text] [Related]
13. An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.
Lanza F; Rack MF; Lynn M; Wolf J; Sanda M
J Rheumatol; 1987 Apr; 14(2):338-41. PubMed ID: 2955117
[TBL] [Abstract][Full Text] [Related]
14. Gastric mucosal adaptation to etodolac and naproxen.
Lipscomb GR; Wallis N; Armstrong G; Goodman MJ; Rees WD
Aliment Pharmacol Ther; 1995 Aug; 9(4):379-85. PubMed ID: 8527613
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of the efficacy and comparative effects on gastric and duodenal mucosa of etodolac and naproxen in patients with rheumatoid arthritis using endoscopy.
Taha AS; McLaughlin S; Sturrock RD; Russell RI
Br J Rheumatol; 1989 Aug; 28(4):329-32. PubMed ID: 2525943
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs.
Luna SP; Basílio AC; Steagall PV; Machado LP; Moutinho FQ; Takahira RK; Brandão CV
Am J Vet Res; 2007 Mar; 68(3):258-64. PubMed ID: 17331014
[TBL] [Abstract][Full Text] [Related]
17. Etodolac compared with aspirin: an endoscopic study of the gastrointestinal tracts of normal volunteers.
Lanza F; Panagides J; Salom IL
J Rheumatol; 1986 Apr; 13(2):299-303. PubMed ID: 2941572
[TBL] [Abstract][Full Text] [Related]
18. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
[TBL] [Abstract][Full Text] [Related]
19. [Application of quantifying scoring systems for the determination of changes in the mucosa of the upper gastrointestinal tract. A comparative study of a diclofenac effervescent tablet with conventional diclofenac preparations and acetylsalicylic acid after repeated administration].
Wildgrube HJ; Kierschke G; Nowak H; Weigmann I; Terhaag B
Arzneimittelforschung; 2002; 52(4):264-72. PubMed ID: 12040969
[TBL] [Abstract][Full Text] [Related]
20. Neutropenia does not prevent etodolac- or indomethacin-induced gastrointestinal damage in the rat.
Melarange R; Gentry C; Toseland CD; Smith PH; Fuller J
Dig Dis Sci; 1995 Dec; 40(12):2694-703. PubMed ID: 8536533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
